New York State Common Retirement Fund
RARX

New York State Common Retirement Fund’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

New York State Common Retirement Fund’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-31,300
Closed -$1.5M – 3381
2020
Q1 		$1.5M Hold
31,300
– – ﹤0.01% 1542
2019
Q4 		$1.47M Sell
31,300
-800
-2% -$35.4K ﹤0.01% 1767
2019
Q3 		$759K Hold
32,100
– – ﹤0.01% 2120
2019
Q2 		$965K Buy
32,100
+16,000
+99% +$367K ﹤0.01% 2036
2019
Q1 		$361K Hold
16,100
– – ﹤0.01% 2456
2018
Q4 		$293K Hold
16,100
– – ﹤0.01% 2533
2018
Q3 		$291K Hold
16,100
– – ﹤0.01% 2665
2018
Q2 		$160K Buy
16,100
+11,600
+258% +$80.1K ﹤0.01% 2976
2018
Q1 		$24K Hold
4,500
– – ﹤0.01% 3062
2017
Q4 		$38K Sell
4,500
-9,400
-68% -$116K ﹤0.01% 3056
2017
Q3 		$203K Hold
13,900
– – ﹤0.01% 2766
2017
Q2 		$260K Buy
13,900
+6,499
+88% +$147K ﹤0.01% 2715
2017
Q1 		$158K Buy
+7,401
New +$142K ﹤0.01% 2854

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

New York State Common Retirement Fund's RARX Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 31,300 shares — an estimated $1.5M sold.

New York State Common Retirement Fund first reported a position in RARX in Q1 2017 and held it in 13 quarters. The position peaked at $1.5M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • New York State Common Retirement Fund reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 31,300 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.5M.
  • New York State Common Retirement Fund first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 13 quarters.
  • New York State Common Retirement Fund's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.5M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.